M. Menken, T. L. Munsat, and J. F. Toole, The global burden of disease study: Implications for neurology, Arch Neurol, vol.57, pp.418-420, 2000.

L. Adams, R. J. Brown, T. M. Carnethon, M. Dai, S. et al., Heart disease and stroke statistics--2010 update: A report from the american heart association, vol.121, pp.46-215, 2010.

W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund et al., Heart disease and stroke statistics--2008 update: A report from the american heart association statistics committee and stroke statistics subcommittee, Circulation, vol.117, pp.25-146, 2008.

D. Carlo, A. Launer, L. J. Breteler, M. M. Fratiglioni, L. Lobo et al., Frequency of stroke in europe: A collaborative study of population-based cohorts. Ilsa working group and the neurologic diseases in the elderly research group. Italian longitudinal study on aging, Neurology, vol.54, pp.28-33, 2000.

J. F. Spieler, J. L. Lanoe, and P. Amarenco, Costs of stroke care according to handicap levels and stroke subtypes, Cerebrovasc Dis, vol.17, pp.134-142, 2004.

J. Kaur, Z. Zhao, G. M. Klein, E. H. Lo, and A. M. Buchan, The neurotoxicity of tissue plasminogen activator?, J Cereb Blood Flow Metab, vol.24, pp.945-963, 2004.

W. Hacke, M. Kaste, E. Bluhmki, M. Brozman, A. Davalos et al., Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke, N Engl J Med, vol.359, pp.1317-1329, 2008.

V. E. O'collins, M. R. Macleod, G. A. Donnan, L. L. Horky, B. H. Van-der-worp et al., 1,026 experimental treatments in acute stroke, Ann Neurol, vol.59, pp.467-477, 2006.

M. A. Moskowitz, E. H. Lo, and C. Iadecola, The science of stroke: Mechanisms in search of treatments, Neuron, vol.67, pp.181-198, 2010.

M. Endres and U. Dirnagl, Ischemia and stroke, Adv Exp Med Biol, vol.513, pp.455-473, 2002.

R. R. Moustafa and J. C. Baron, Pathophysiology of ischaemic stroke: Insights from imaging, and implications for therapy and drug discovery, Br J Pharmacol, vol.153, issue.1, pp.44-54, 2008.

U. Dirnagl, C. Iadecola, and M. A. Moskowitz, Pathobiology of ischaemic stroke: An integrated view, Trends Neurosci, vol.22, pp.391-397, 1999.

H. Naess, U. Waje-andreassen, and H. Nyland, Risk factor burden predicts long-term mortality in young patients with arterial cerebral infarction, Acta neurologica Scandinavica, 2012.

C. L. Allen and U. Bayraktutan, Risk factors for ischaemic stroke, Int J Stroke, vol.3, pp.105-116, 2008.

N. Blondeau and J. S. Tauskela, A new future in brain preconditioning based on nutraceuticals: A focus on a-linolenic omega-3 fatty acid for stroke protection, vol.16, 2012.

, World Health Organization. Who and fao joint consultation: Fats and oils in human nutrition, Nutr Rev, vol.53, pp.202-205, 1995.

R. T. Holman, Nutritional and metabolic interrelationships between fatty acids, Fed Proc, vol.23, pp.1062-1067, 1964.

J. T. Brenna, N. Salem, J. Sinclair, A. J. Cunnane, and S. C. , Alpha-linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans, Prostaglandins Leukot Essent Fatty Acids, vol.80, pp.85-91, 2009.

E. A. Emken, R. O. Adlof, and R. M. Gulley, Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males, Biochim Biophys Acta, vol.1213, pp.277-288, 1994.

K. F. Michaelsen, K. G. Dewey, A. B. Perez-exposito, M. Nurhasan, L. Lauritzen et al., Food sources and intake of n-6 and n-3 fatty acids in low-income countries with emphasis on infants, young children (6-24 months), and pregnant and lactating women, Matern Child Nutr, vol.7, issue.2, pp.124-140, 2011.

E. K. Kalra, Nutraceutical--definition and introduction, AAPS PharmSci, vol.5, p.25, 2003.

N. Hussein, E. Ah-sing, P. Wilkinson, C. Leach, B. A. Griffin et al., Longchain conversion of [13c]linoleic acid and alpha-linolenic acid in response to marked changes in their dietary intake in men, J Lipid Res, vol.46, pp.269-280, 2005.

R. J. Pawlosky, J. R. Hibbeln, J. A. Novotny, N. Salem, and J. , Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans, J Lipid Res, vol.42, pp.1257-1265, 2001.

G. Barcelo-coblijn and E. J. Murphy, Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: Benefits for human health and a role in maintaining tissue n-3 fatty acid levels, Prog Lipid Res, vol.48, pp.355-374, 2009.

G. C. Burdge and P. C. Calder, Dietary alpha-linolenic acid and health-related outcomes: A metabolic perspective, Nutr Res Rev, vol.19, pp.26-52, 2006.

C. Wang, W. S. Harris, M. Chung, A. H. Lichtenstein, E. M. Balk et al., N-3 fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary-and secondary-prevention studies: A systematic review, Am J Clin Nutr, vol.84, pp.5-17, 2006.

J. Tinoco, Dietary requirements and functions of alpha-linolenic acid in animals

, Prog Lipid Res, vol.21, pp.1-45, 1982.

V. R. King, W. L. Huang, S. C. Dyall, O. E. Curran, J. V. Priestley et al.,

, Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat, J Neurosci, vol.26, pp.4672-4680, 2006.

S. C. Dyall and M. At, Neurological benefits of omega-3 fatty acids, Neuromolecular Med, vol.10, pp.219-235, 2008.

M. At, Omega-3 fatty acids and neurological injury, Prostaglandins Leukot Essent Fatty Acids, vol.77, pp.295-300, 2007.

N. Blondeau, C. Widmann, M. Lazdunski, and C. Heurteaux, Polyunsaturated fatty acids induce ischemic and epileptic tolerance, Neuroscience, vol.109, pp.231-241, 2002.
URL : https://hal.archives-ouvertes.fr/hal-00090948

I. Lauritzen, N. Blondeau, C. Heurteaux, C. Widmann, G. Romey et al., Polyunsaturated fatty acids are potent neuroprotectors, EMBO J, vol.19, pp.1784-1793, 2000.

N. Blondeau, C. Nguemeni, D. N. Debruyne, M. Piens, X. Wu et al., Subchronic alpha-linolenic acid treatment enhances brain plasticity and exerts an antidepressant effect: A versatile potential therapy for stroke, Neuropsychopharmacology, vol.34, pp.2548-2559, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00418411

S. Rabinovitz, D. I. Mostofsky, and S. Yehuda, Anticonvulsant efficiency, behavioral performance and cortisol levels: A comparison of carbamazepine (cbz) and a fatty acid compound (sr-3), Psychoneuroendocrinology, vol.29, pp.113-124, 2004.

A. P. Simopoulos, The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases, Exp Biol Med (Maywood), vol.233, pp.674-688, 2008.

L. Djousse, S. C. Hunt, D. K. Arnett, M. A. Province, J. H. Eckfeldt et al., Dietary linolenic acid is inversely associated with plasma triacylglycerol: The national heart, lung, and blood institute family heart study, Am J Clin Nutr, vol.78, pp.1098-1102, 2003.

J. A. Simon, J. Fong, J. T. Bernert, J. Browner, and W. S. , Serum fatty acids and the risk of stroke, Stroke, vol.26, pp.778-782, 1995.

C. Heurteaux, N. Guy, C. Laigle, N. Blondeau, F. Duprat et al., Trek-1, a k+ channel involved in neuroprotection and general anesthesia, EMBO J, vol.23, pp.2684-2695, 2004.

N. Blondeau, O. Petrault, S. Manta, V. Giordanengo, P. Gounon et al., Polyunsaturated fatty acids are cerebral vasodilators via the trek-1 potassium channel, Circ Res, vol.101, pp.176-184, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00171737

A. Garry, B. Fromy, N. Blondeau, D. Henrion, F. Brau et al., Altered acetylcholine, bradykinin and cutaneous pressure-induced vasodilation in mice lacking the trek1 potassium channel: The endothelial link, EMBO Rep, vol.8, pp.354-359, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00171740

T. Shimokawa, A. Moriuchi, T. Hori, M. Saito, Y. Naito et al.,

M. Matsubara and H. Okuyama, Effect of dietary alpha-linolenate/linoleate balance on mean survival time, incidence of stroke and blood pressure of spontaneously hypertensive rats, Life Sci, vol.43, pp.2067-2075, 1988.

C. Heurteaux, C. Laigle, N. Blondeau, G. Jarretou, and M. Lazdunski, Alpha-linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia, Neuroscience, vol.137, pp.241-251, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00091215

N. Blondeau, C. Widmann, M. Lazdunski, and C. Heurteaux, Activation of the nuclear factor-kappab is a key event in brain tolerance, J Neurosci, vol.21, pp.4668-4677, 2001.

C. Nguemeni, B. Delplanque, C. Rovere, N. Simon-rousseau, C. Gandin et al., Dietary supplementation of alpha-linolenic acid in an enriched rapeseed oil diet protects from stroke, Pharmacol Res, vol.61, pp.226-233, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00497117